exRNAdisease

Entry Detail

---



General Information

Database ID: exR0263001 RNA Name: hsa-miR-516b-5p RNA Type: miRNA Chromosome: chr19 Starnd: + Coordinate: Start Site(bp): 53736860 End Site(bp): 53736881 External Links: hsa-miR-516b-5p

Disease Information

Disease Name: Prostate Cancer Disease Category: Cancers MeSH ID: D011471 Type: Neoplasms/Digestive System Neoplasms Alias: Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate

Expression Detail

GEO ID: GSE134266 Description: Deep sequencing identified serum extracellular vesicle delivered miR-181a-5p as an indicator for bone-metastatic prostate cancer (microarray) Experimental Design: Cancer vs Control Case Disease Type: Prostate Cancer Case Disease SubType: Bone Metastatic Prostate Cancer Case Sample: Bone Metastatic Prostate Cancer Control Sample: Benign Prostatic Hyperplasia Number of Case: 8 Number of Control: 9 Number of Samples: 17

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand BCL2L11 chr2 111119378 111168445 + CHKB-CPT1B chr22 50568869 50582965 - CPT1B chr22 50568861 50578465 - DNAJC9 chr10 73183362 73247255 - FAM13B chr5 137937960 138051961 - FNBP4 chr11 47716494 47767443 - FOSL2 chr2 28392448 28417317 + FSD1 chr19 4304598 4323843 + GOLGA1 chr9 124878275 124948492 - HIF1AN chr10 100529072 100559998 + MAK16 chr8 33485182 33501262 + NEMP1 chr12 57055643 57088063 - NID1 chr1 235975830 236065109 - PIGS chr17 28553383 28571794 - QSER1 chr11 32892820 32993316 + RABGAP1 chr9 122940833 123104866 + S100A16 chr1 153606886 153613145 - SGPP1 chr14 63684216 63728065 - STAT3 chr17 42313324 42388568 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000698 chr16 47531309 47549512 + hsa_circ_0001727 chr7 99621041 99621930 + hsa_circ_0001495 chr5 68470703 68471364 + hsa_circ_0000825 chr18 8718421 8720494 + hsa_circ_0001387 chr4 1902352 1936989 + hsa_circ_0000038 chr1 28800065 28802803 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC016876.2 chr17 7581964 7584086 - AC079781.5 chr7 97851688 97972985 - AL157392.3 chr10 13631143 13668445 + COL4A2-AS2 chr13 110456396 110463287 - LINC00324 chr17 8220642 8224043 - LINC01184 chr5 127939152 128083172 - MIR194-2HG chr11 64889560 64893449 - NEAT1 chr11 65422774 65445540 + PCBP1-AS1 chr2 69962263 70103220 - TBC1D3P1-DHX40P1 chr17 59962363 60018975 - TUG1 chr22 30969245 30979395 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE134266 Sample Source: Blood Source Fraction: Extracellular Vesicle Platform: GPL25134 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2519 Sample treatment protocol: The blood was centrifuged at 2000 g for 10 min at 4 °C to extract the serum. The serum EV was extracted using Total Exosome Isolation Kit (from serum, Thermo fisher scientific). RNA Extract protocol: Exosome Purification and RNA Isolation Kit (Norgen Biotek) was employed to purify EV and extract total RNA in EV consequentially. RNA library preparation protocol: Sample tag and reagents are included in the hybrid need Agilent's micrornas Complete Labeling and Hyb Kit (p/n 5190-0456).

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA